Aberle DR, Adams AM, Berg CD, Black WC, Clapp JD, Fagerstrom RM, et al. Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med. 2011;365:395–409.
Article
PubMed
Google Scholar
Paci E, Puliti D, Lopes Pegna A, Carrozzi L, Picozzi G, Falaschi F, et al. Mortality, survival and incidence rates in the ITALUNG randomised lung cancer screening trial. Thorax. 2017;72:825–31.
Article
PubMed
Google Scholar
Sheehan DF, Criss SD, Gazelle GS, Pandharipande PV, Kong CY. Evaluating lung cancer screening in China: implications for eligibility criteria design from a microsimulation modeling approach. PLoS ONE. 2017;12:e0173119. https://doi.org/10.1371/journal.pone.0173119.
Article
PubMed
PubMed Central
CAS
Google Scholar
Wang Z, Wei H, Zhang W, Xue F, Wang Y, Hu Y, et al. Mortality outcomes of low-dose computed tomography screening for lung cancer in urban China: a decision analysis and implications for practice. Chin J Cancer. 2017;36:57. https://doi.org/10.1186/s40880-017-0221-8.
Article
PubMed
PubMed Central
Google Scholar
Zhou QH, Fan YG, Bu H, Wang Y, Wu N, Huang YC, et al. China national lung cancer screening guideline with low-dose computed tomography (2015 version). Thorac Cancer. 2015;6:812–8.
Article
PubMed
PubMed Central
Google Scholar
Centers for Medicare & Medicaid Services. Decision memo for screening for lung cancer with low dose computed tomography. https://www.acr.org/~/media/ACR/Documents/PDF/QualitySafety/NRDR. Accessed 25 Sept 2017.
Baldwin DR, Duffy SW, Devaraj A, Field JK. Optimum low dose CT screening interval for lung cancer: the answer from NELSON? Thorax. 2017;72:6–7.
Article
PubMed
Google Scholar
World Health Organization. GLOBOCAN 2012: estimated cancer incidence, mortality and prevalence worldwide in 2012. http://globocan.iarc.fr/Pages/fact_sheets_population.aspx. Accessed 10 Sept 2017.
Zhao SJ, Wu N. Early detection of lung cancer: low-dose computed tomography screening in China. Thorac Cancer. 2015;6:385–9.
Article
PubMed
PubMed Central
Google Scholar
Heuvelmans MA, Vliegenthart R, Oudkerk M. Contributions of the European trials (European randomized screening group) in computed tomography lung cancer screening. J Thorac Imaging. 2015;30:101–7.
Article
PubMed
Google Scholar
Katki HA, Kovalchik SA, Berg CD, Cheung LC, Chaturvedi AK. Development and validation of risk models to select ever-smokers for CT lung-cancer screening. JAMA. 2016;315:2300–11.
Article
PubMed
PubMed Central
CAS
Google Scholar
Sagawa M, Sugawara T, Ishibashi N, Koyanagi A, Kondo T, Tabata T. Efficacy of low-dose computed tomography screening for lung cancer: the current state of evidence of mortality reduction. Surg Today. 2017;47:783–8.
Article
PubMed
Google Scholar
Tang W, Wu N, Huang Y, Wang J, Zhao S, Xu Z, et al. Results of low-dose computed tomography (LDCT) screening for early lung cancer: prevalence in 4 690 asymptomatic participants. Chin J Oncol. 2014;36:549–54.
Google Scholar
Walter JE, Heuvelmans MA, de Jong PA, Vliegenthart R, van Ooijen PMA, Peters RB, et al. Occurrence and lung cancer probability of new solid nodules at incidence screening with low-dose CT: analysis of data from the randomised, controlled NELSON trial. Lancet Oncol. 2016;17:907–16.
Article
PubMed
Google Scholar
Yousaf-Khan U, van der Aalst C, de Jong PA, Heuvelmans M, Scholten E, Lammers J, et al. Final screening round of the NELSON lung cancer screening trial: the effect of a 2.5 years screening interval. Thorax. 2017;72:48–56.
Article
PubMed
Google Scholar
Sverzellati N, Silva M, Calareso G, Galeone C, Marchianò A, Sestini S, et al. Low-dose computed tomography for lung cancer screening: comparison of performance between annual and biennial screen. Eur Radiol. 2016;26:3821–9.
Article
PubMed
Google Scholar
Yousaf-Khan U, van der Aalst C, de Jong PA, Heuvelmans M, Scholten E, Walter J, et al. Risk stratification based on screening history: the NELSON lung cancer screening study. Thorax. 2017;72:819–24.
Article
PubMed
Google Scholar
Wang Z, Hu Y, Wang Y, Han W, Wang L, Xue F, et al. Can CT screening give rise to a beneficial stage shift in lung cancer patients? Systematic review and meta-analysis. PLoS ONE. 2016;11:e0164416. https://doi.org/10.1371/journal.pone.0164416.
Article
PubMed
PubMed Central
Google Scholar
National Research Council (US) Committee on a framework for developing a new taxonomy of disease. Toward precision medicine: building a knowledge network for biomedical research and a new taxonomy of disease. Washington (DC): National Academies Press (US); 2011.
Hasan N, Kumar R, Kavuru MS. Lung cancer screening beyond low-dose computed tomography: the role of novel biomarkers. Lung. 2014;192:639–48.
Article
PubMed
Google Scholar
Veronesi G, Bianchi F, Infante M, Alloisio M. The challenge of small lung nodules identified in CT screening: can biomarkers assist diagnosis? Biomarkers Med. 2016;10:137–43.
Article
CAS
Google Scholar
Carozzi FM, Bisanzi S, Carrozzi L, Falaschi F, Lopes Pegna A, Mascalchi M, et al. Multimodal lung cancer screening using the ITALUNG biomarker panel and low dose computed tomography. Results of the ITALUNG biomarker study. Int J Cancer. 2017;141:94–101.
Article
PubMed
CAS
Google Scholar
Sullivan FM, Farmer E, Mair FS, Treweek S, Kendrick D, Jackson C, et al. Detection in blood of autoantibodies to tumour antigens as a case-finding method in lung cancer using the EarlyCDT®-Lung Test (ECLS): study protocol for a randomized controlled trial. BMC Cancer. 2017;17:187. https://doi.org/10.1186/s12885-017-3175-y.
Article
PubMed
PubMed Central
CAS
Google Scholar
Shen J, Liu Z, Todd NW, Zhang H, Liao J, Yu L, et al. Diagnosis of lung cancer in individuals with solitary pulmonary nodules by plasma microRNA biomarkers. BMC Cancer. 2011;11:374. https://doi.org/10.1186/1471-2407-11-374.
Article
PubMed
PubMed Central
CAS
Google Scholar
Heuvelmans MA, Vliegenthart R, de Koning HJ, Groen HJM, van Putten MJAM, Yousaf-Khan U, et al. Quantification of growth patterns of screen-detected lung cancers: the NELSON study. Lung Cancer. 2017;108:48–54.
Article
PubMed
Google Scholar
Jamal-Hanjani M, Wilson GA, Mcgranahan N, Birkbak NJ, Watkins TBK, Veeriah S, et al. Tracking the evolution of non-small-cell lung cancer. N Engl J Med. 2017;376:2109.
Article
PubMed
CAS
Google Scholar
Yao N, Wang J, Cai Y, Yuan J, Wang H, Gong J, et al. Patterns of cancer screening, incidence and treatment disparities in China: protocol for a population-based study. BMJ Open. 2016;6:e012028. https://doi.org/10.1136/bmjopen-2016-012028.
Article
PubMed
PubMed Central
Google Scholar
Yousaf-Khan AU, van der Aalst CM, Aerts JGJV, den Bakker MA, de Koning HJ. Uniform and blinded cause of death verification of the NELSON lung cancer screening participants. Lung Cancer. 2017;111:131–4.
Article
PubMed
CAS
Google Scholar
Guo Y, Zeng H, Zheng R, Li S, Pereira G, Liu Q, et al. The burden of lung cancer mortality attributable to fine particles in China. Sci Total Environ. 2017;579:1460–6.
Article
PubMed
CAS
Google Scholar
Brain K, Carter B, Lifford KJ, Burke O, Devaraj A, Baldwin DR, et al. Impact of low-dose CT screening on smoking cessation among high-risk participants in the UK Lung Cancer Screening Trial. Thorax. 2017;72:912–8.
Article
PubMed
PubMed Central
Google Scholar